MetaADEDB 2.0 @ LMMD
Chlorzoxazone
(TZFWDZFKRBELIQ-UHFFFAOYSA-N)
Structure
SMILES
Clc1ccc2c(c1)[nH]c(=O)o2
Type(s)
Approved
ATC code(s)
M03BB03; M03BB53; M03BB73
Molecular Formula:
C7H4ClNO2
Molecular Weight:
169.565
Log P:
1.7745
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
1
TPSA:
46
CAS Number(s):
95-25-0
Synonym(s)
1.
Chlorzoxazone
2.
Paraflex
3.
Parafon
4.
Parafon Forte DSC
External Link(s)
MeSHD002753
PubChem Compound2733
BindingDB50290811
ChEBI3655
CHEMBLCHEMBL1371
DrugBankDB00356
DrugCentral626
IUPHAR/BPS Guide to PHARMACOLOGY2322
KEGGcpd:C07931
dr:D00771
Therapeutic Target DatabaseD08ZEB
ZINC84843283
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1DizzinessFAERS: 19SIDER
US FAERS
2SomnolenceFAERS: 16SIDER
US FAERS
3Drug ineffectiveFAERS: 13US FAERS
4Drug dose omissionFAERS: 9US FAERS
5HeadacheFAERS: 6US FAERS
6NauseaFAERS: 6US FAERS
7UrticariaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
8FatigueFAERS: 4US FAERS
9MalaiseFAERS: 4SIDER
US FAERS
10PruritusFAERS: 4US FAERS
11Abdominal PainFAERS: 3US FAERS
12Abdominal discomfortFAERS: 3US FAERS
13ChromaturiaFAERS: 3OFFSIDES
SIDER
US FAERS
14PainFAERS: 3OFFSIDES
US FAERS
15Product use issueFAERS: 3US FAERS
16TremorFAERS: 3US FAERS
17jaundiceFAERS: 39828666CTD
US FAERS
18Adverse eventFAERS: 2US FAERS
19Back PainFAERS: 27299979CTD
US FAERS
20FlushingFAERS: 2US FAERS
21HypersensitivityFAERS: 2US FAERS
22VertigoFAERS: 2US FAERS
23VomitingFAERS: 2US FAERS
24AcidosisFAERS: 1US FAERS
25Anaphylactic shockFAERS: 1SIDER
US FAERS
26AngioedemaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
27Ankle FractureFAERS: 1US FAERS
28AnorexiaFAERS: 1OFFSIDES
US FAERS
29AscitesFAERS: 1US FAERS
30Bacterial VaginosisFAERS: 1US FAERS
31BradycardiaFAERS: 1OFFSIDES
US FAERS
32ConstipationFAERS: 1US FAERS
33Drug screen false positiveFAERS: 1US FAERS
34DysgeusiaFAERS: 1US FAERS
35Epigastric discomfortFAERS: 1US FAERS
36EpistaxisFAERS: 1US FAERS
37Euphoric moodFAERS: 1US FAERS
38HepatotoxicityFAERS: 1US FAERS
39HyperchlorhydriaFAERS: 1US FAERS
40Inappropriate schedule of drug administrationFAERS: 1US FAERS
41Intervertebral Disc DegenerationFAERS: 1OFFSIDES
US FAERS
42Lactose IntoleranceFAERS: 1US FAERS
43Mental status changesFAERS: 1US FAERS
44Myocardial InfarctionFAERS: 1US FAERS
45NasopharyngitisFAERS: 1US FAERS
46PalpitationsFAERS: 1US FAERS
47Product quality issueFAERS: 1US FAERS
48TinnitusFAERS: 1US FAERS
49Abnormal visionOFFSIDES
50AcneOFFSIDES
51Actinic keratosisOFFSIDES
52AgraphiaOFFSIDES
53Alanine Aminotransferase IncreasedOFFSIDES
54Alcoholic IntoxicationOFFSIDES
55AlopeciaOFFSIDES
56AmenorrheaOFFSIDES
57Ammonia increasedOFFSIDES
58AmnesiaOFFSIDES
59AnxietyOFFSIDES
60ArteriosclerosisOFFSIDES
61AstheniaOFFSIDES
62AsthmaOFFSIDES
63AstigmatismOFFSIDES
64Bladder spasmOFFSIDES
65BlepharospasmOFFSIDES
66Blood GlucoseOFFSIDES
67Blood creatinine increasedOFFSIDES
68Blood potassium decreasedOFFSIDES
69Body TemperatureOFFSIDES
70Central nervous system lesionOFFSIDES
71Cerebral artery occlusionOFFSIDES
72Cervicobrachial syndromeOFFSIDES
73Chemical and Drug Induced Liver Injury7299979
9828666
18524759
CTD
74CholangiolitisOFFSIDES
75Chronic Obstructive Airway DiseaseOFFSIDES
76Circumstance or information capable of leading to medication errorOFFSIDES
77Completed SuicideOFFSIDES
78Complications of transplant surgeryOFFSIDES
79Congenital tricuspid valve incompetenceOFFSIDES
80DependenceOFFSIDES
81DermatitisSIDER
82Diabetes mellitus inadequate controlOFFSIDES
83DiscomfortSIDER
84Disorders of Excessive Somnolence7299979CTD
85DrowsinessOFFSIDES
SIDER
86Drug dispensing errorOFFSIDES
87DyspepsiaOFFSIDES
SIDER
88DysphoniaOFFSIDES
89DysuriaOFFSIDES
90EcchymosisSIDER
91Economic problemOFFSIDES
92Electrocardiogram QRS complexOFFSIDES
93Embolic strokeOFFSIDES
94Escherichia infectionOFFSIDES
95Excessive eye blinkingOFFSIDES
96Facial NeuralgiaOFFSIDES
97Feeling abnormalSIDER
98FibromyalgiaOFFSIDES
99GalactorrheaOFFSIDES
100Gastric infectionOFFSIDES
101Gastrointestinal Diseases7299979CTD
102GlobulinuriaOFFSIDES
103GranulocytosisOFFSIDES
104Head deformityOFFSIDES
105HyperventilationOFFSIDES
106Hypoaesthesia facialOFFSIDES
107Hypocoagulable stateOFFSIDES
108ImmunosuppressionOFFSIDES
109Impaired driving abilityOFFSIDES
110IncontinenceOFFSIDES
111InfectionOFFSIDES
112Intention tremorOFFSIDES
113Intentional drug misuseOFFSIDES
114Joint sprainOFFSIDES
115LightheadednessSIDER
116Liver Failure, Acute17390222CTD
117Liver transplant rejectionOFFSIDES
118Low Back Pain17390222CTD
119Lumbar radiculopathyOFFSIDES
120MalabsorptionOFFSIDES
121Mechanical ventilationOFFSIDES
122MononeuritisOFFSIDES
123Multiple drug overdoseOFFSIDES
124Multiple drug overdose intentionalOFFSIDES
125Muscle tightnessOFFSIDES
126MyalgiaCanada Vigilance: 1Canada Vigilance
127MyopiaOFFSIDES
128Nervous tensionOFFSIDES
129Ocular icterusOFFSIDES
130OrthopneaOFFSIDES
131OverdoseOFFSIDES
132PetechiaeSIDER
133Pharmaceutical product complaintOFFSIDES
134PresbyopiaOFFSIDES
135Protein S decreasedOFFSIDES
136Protein total decreasedOFFSIDES
137Psychomotor skills impairedOFFSIDES
138PyelonephritisOFFSIDES
139Radicular painOFFSIDES
140Rhabdomyolysis10322565CTD
141Semen volume decreasedOFFSIDES
142Sinus bradycardiaOFFSIDES
143SinusitisOFFSIDES
144Sleep-related eating disorderOFFSIDES
145Spasm7299979CTD
146StressOFFSIDES
147Torticollis7299979CTD
148Unresponsive to stimuliOFFSIDES
149Vasculitis, Leukocytoclastic, Cutaneous14746633CTD
150Weight GainOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.